Blog

Regulatory Affairs Blog

LabCorp Expands Drug Development Solutions with Acquisition of Sciformix

Sciformix extends Covance’s pharmacovigilance capabilities for post-approval safety solutions BURLINGTON, N.C.–(BUSINESS WIRE)–Jun. 11, 2018– LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions...
Ambika Subramanian, Regulatory Affairs Specialist at Sciformix.

Lean Medical Writing: A Critical Skill to Hone

Well-written documents, whether intended for regulatory submissions (clinical study reports, investigator’s brochure, clinical and non-clinical overviews and summaries, safety reports, etc), publications, medico marketing or other purposes, can have a significant effect on the market, industry, regulators and the perception of the...